Previous Article | Next Article 
Journal of Virology, May 2001, p. 4540-4550, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4540-4550.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Variation in Adenovirus Transgene Expression between BALB/c and
C57BL/6 Mice Is Associated with Differences in Interleukin-12 and
Gamma Interferon Production and NK Cell Activation
YuFeng
Peng,1
Erik
Falck-Pedersen,2 and
Keith B.
Elkon1,*
Departments of
Medicine1 and Microbiology and
Immunology,2 Weill Medical College of
Cornell University, New York, New York 10021
Received 30 October 2000/Accepted 13 February 2001
 |
ABSTRACT |
The innate immune response against replication-defective
adenoviruses (Ad) is poorly defined. We and others have previously observed striking differences in the rate at which the Ad vector itself
or the virus encoding a variety of transgenes is eliminated in
different mouse strains. Here, we report that Ad infection of BALB/
mice is associated with sixfold-higher levels of serum alanine
aminotransferase and that Ad transgenes induce two- to threefold-higher
levels of intrahepatic NK cells and NK activity compared to C57BL/6
mice. The increase in NK activation in BALB/c mice was associated with
~4-fold higher level of mRNA expression of a newly described NKG2
receptor activator, H-60, as well as increased expression of
interleukin-12 and gamma interferon mRNAs in BALB/c mice compared to
C57BL/6 mice. NK depletion in BALB/c mice or defective NK function in
C3H beige mice extended transgene expression compared to their
appropriate controls, and attenuation of NK together with CD8 T-cell
function had a synergistic effect. These findings indicate that there
are intrinsic differences in the innate immune responses of different
mouse strains to Ad and Ad transgenes and that NK cells, in cooperation
with CD8 T cells, play a pivotal role in the early extinction of
transgene expression in BALB/c mice.
 |
INTRODUCTION |
It is now well established that the
major obstacle to adenovirus (Ad)-mediated gene therapy is the
induction of a robust immune response to, and elimination of,
virus-infected cells (reviewed in reference 34). Whereas
the role of conventional lymphocyte subsets has been fairly extensively
evaluated (36), little attention has been paid to the
innate immune response to the replication-defective virus. Early
responses are particularly important to define in view of the potential
for high-dose Ad gene therapy to cause mortality (14).
Based on the evidence that CD8+ T cells play a dominant
role in elimination of replication-defective Ad (36), we
recently demonstrated that an Ad-encoded soluble CD8 (sCD8) protein
could prolong transgene expression in C57BL/6 (B6) and C3H mice
(20). Unlike these two strains of mice however, BALB/c
mice rapidly eliminated the Ad vector expressing sCD8. Paradoxically,
in vitro studies revealed that splenic T cells obtained from BALB/c
mice were less activated and exhibited less antigen-specific
cytotoxicity after restimulation compared to B6 mice (20).
This finding suggested that the rapid extinction of transgene
expression was most likely facilitated by non-CD8 effector cell(s).
Most virus infections of mammalian cells activate natural killer (NK)
cells (2, 16) through modulation of major
histocompatibility complex class I on the surface of infected cells
and/or by the release of cytokines such as interleukin-12 (IL-12),
IL-18, and gamma interferon (IFN-
) (2). Very recently,
ligands responsible for activating NK cells through the lectin-like
NKG2 receptor have been identified, but their roles in virus infections
have not been delineated (3). Once triggered, NK cells
secrete large amounts of IFN-
, a cytokine that not only amplifies
the innate immune response of NK cells and macrophages but also
activates CD8+ T cells (2). To determine
whether NK cells contributed to the innate immune response to Ad
vectors and could explain the rapidity of transgene silencing in BALB/c
mice, we evaluated the early cytokine response and the role of NK cells
in Ad-infected mice. The results of these studies indicate that BALB/c
mice have persistent IL-12 expression associated with enhanced NK activity.
 |
MATERIALS AND METHODS |
Mice.
C57BL/6 (H2b), BALB/c/J
(H2d), C3H/HeJ (H2k), and
beige C3H/HeJ (H2k) mice and IL-12 p35-deficient
mice in the BALB/c/J (H2d) background were
purchased from Jackson Laboratory, Bar Harbor, Maine. BALB/c.SCID mice
were bred and maintained at the Hospital for Special Surgery in a
pathogen-free environment.
Ad-encoded transgenes.
All viruses used in this study,
including Ad null, lacked E1 and E3 (Ad type 5) and were replication
defective (20). Ad type 5 expressing the ectodomain of
murine CD8-
(Ly2.1) or chloramphenicol acetyltransferase (CAT)
(AdsCD8 or AdCAT) was produced as described elsewhere
(20). Briefly, the pAd vector containing the transgene was
cotransfected with PJM17 into 293 cells. The cell lysate was used to
infect 293 cells. Viral DNA was extracted by a modified Hirt assay, and
recombination was verified by restriction enzyme digestion, PCR, and
protein production (see below). The viruses were further plaque
purified. Each clone was rescreened as above. Finally, large-scale
virus was purified by two-step CsCl concentration and stored in
glycerol at
20°C or sucrose at
70°C. Quantitation of viral
particles was measured at optical density at (OD) 260 nm.
Injection of mice with Ad vectors and evaluation of virus
expression.
Mice were injected with 2.0 × 1010
particles of virus by the intravenous route unless indicated otherwise
and bled at 7- or 14-day intervals. Persistence of transgene expression
was determined by detection of the transgene product secreted into the
serum (sCD8) or by protein expression in the liver (CAT) as described previously (21). In brief, CAT activity in liver
homogenates was quantified by thin-layer chromatography of
14C-labeled substrate (21), and secreted
transgene products by were quantitated by enzyme-linked immunosorbent
assay (ELISA) as described below. To verify active transcription of
transgenes, we isolated total RNA from liver homogenates and performed
PCR amplification of the transgene with primers (5' to 3') that were specific for Ad sequences immediately flanking the transgenes (CCCAGGTCCAACTGCAGCCC and GGTACTTGTGAGCCAAGGCAG).
The amplification conditions were 35 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 50 s. PCR of
-actin
with the primers CCCTGGCTGCCTCAACACC and
GAGCAAACATCCCCCAAAGT was used as a control.
Antibodies and flow cytometry analysis.
Flow cytometry
analysis was performed using a FACScan with CellQuest software (Becton
Dickinson, Mountain View, Calif.) as described previously
(21). Monoclonal antibodies against the following antigens
were used for staining: CD4 (PharMingen, San Diego, Calif.); CD8
(PharMingen); and DX5 (PharMingen), a pan-NK cell marker.
Isolation of IHL.
Intrahepatic lymphocytes (IHL) were
isolated as described by Watanabe et al. (33). Briefly,
livers from day 10-infected mice were perfused with 10 ml of Hanks
buffered salt solution and cut into small pieces. These small pieces
were forced through a metal mesh. The liver slurry was digested with
liver digestion medium (Gibco) at 37°C for 40 min followed by
washing. The cell pellet was resuspended in 35 ml (two livers) of
medium (RPMI 1640 supplemented with 10% fetal calf serum) and
centrifuged through 15 ml of Ficoll (Amersham Pharmacia
Ficoll-Hypaque). IHL were collected at the interface, washed, and used
for phenotypic or functional assays.
In vivo and in vitro cytotoxicity assays.
The serum levels
of glutamic pyruvic transaminase/alanine aminotransferase (ALT), a
marker of hepatocyte injury in vivo, was quantified using a commercial
diagnostic kit (Sigma) (26). Ex vivo CD8 T-cell
cytotoxicity was performed using the appropriate major
histocompatibility complex-matched cells (C57SV,
H2b for B6; SVBALB, H2d
for BALB/c [28]) as targets. The target cells were
labeled with [3H]thymidine (5 µCi/ml) (15)
and infected with AdCAT (multiplicity of infection of 100). The next
day, the labeled infected cells were used as targets for cytotoxic T
lymphocytes (CTI) at different effector/target (E/T) ratios. Lysis was
allowed to proceed for 5 h, after which the plates were
extensively washed and the remaining cells were detached with
trypsin-EDTA (Gibco). The cells were harvested and counted in a
Microbeta Trilux scintillation counter (Wallac, Gaithersburg, Md.). The
percentage of specific lysis was calculated from the formula
100 × [(S
E)/S], where S and E are the spontaneous and experimental counts per minute,
respectively. Standard deviations (SD) were derived from triplicates
within experiments.
NK cell cytotoxicity was evaluated by a Cr release assay. Spleen cells
or IHL were incubated with 51Cr-labeled YAC-1 cells at
various E/T ratios, and release of Cr was quantified on a
counter.
The percentage of lysis was calculated according to the formula [(cpm
sample
cpm spontaneous)/(cpm maximum
cpm spontaneous)] × 100. As a control for specificity, infected mice were pretreated
with anti-asialo GM1 antibody (anti-GM1) to deplete NK cell activity
(see below).
ELISAs.
CD8 levels in mouse serum were quantified by
sandwich ELISAs using two different monoclonal antibodies to the mouse
CD8
chain, TIB 105 hybridoma (American Type Culture Collection) and biotinylated mouse YST 169 (CALTAG Laboratories, Burlingame, Calif.). ELISA plates were coated overnight with TIB 105 (5 µg/ml) at 4°C. The plates were blocked with phosphate-buffered saline-3% bovine serum albumin for 1 h at room temperature and then incubated with the 1/3-diluted serum sample for 4 to 5 h in room temperature. The
plates were washed and sequentially incubated with biotinylated secondary antibody, avidin-alkaline phosphatase, and substrate. The OD
was read at 405 nm. The level of expression of each protein in the
serum was normalized to the peak level of the corresponding protein in
SCID mouse serum as calculated by relative expression (OD of test
sample/OD of SCID serum). IFN-
production by day 7 AdCAT-infected
mice was quantified following incubation of IHL with YAC-1 cells at a
ratio of 1:10 at 37°C for 24 h. In some cases, IL-12 (10 ng/ml)
was added. IFN-
in the supernatant was quantified using a sandwich
ELISA (PharMingen) with R4-6A2 as capture antibody, biotinylated XMG1.2
as detecting antibody, and purified recombinant IFN-
(Gibco BRL,
Grand Island, N.Y.) as a standard.
Cytokine mRNA expression.
To compare the cytokine profiles
induced by Ad vector infection, spleen and liver RNA samples were
collected at days 0, 3, and 7 postinfection. Liver (100 µg) or spleen
(30 µg) RNA was hybridized with in vitro-transcribed MCK-2b template
(PharMingen). The RNase protection assay was performed according to the
manufacturer's instructions. Semiquantitative assessment of IFN-
,
H-60, and IL-12 p35 and p40 subunit expression was performed using the
following primer pairs: IFN-
(5'
3'),
CATGGCTGTTTCTGGCTGTTACTG and TTGGCGCTGGACCTGTGG (94°C for 30 s, 65°C for 45 s, and 72°C for 1 min; 30 cycles); H-60 (5'
3'), TGTGCTGATTTGTCCCAAAA and
CCGGCACCTTTAATGTTGAT (94°C for 30 s, 55°C for
45 s, and 72°C for 1 min; 30 cycles); p35 (5'
3'), TGCCAGGTGTCTTAGCCAGGTCC and CGCAGAGTCTCGCCATTAT
(94°C for 30 s, 62°C for 45 s, and 72°C for 1 min; 35 cycles); p40 ACCTGTGACACGCCTGAAGA and
TGATGATGTCCCTGATGAGAAGC (94°C for 30 s, 62°C for
45 s, and 72°C for 1 min; 32 cycles). mRNA expression was
quantified by densitometry.
Depletion and repletion of NK cells.
Depletion of NK cells
was performed as instructed by the manufacturer. Briefly, 25 µl of
anti-GM1 (Wako Chemical USA, Richmond, Va.) was injected every 4 to 5 days intravenously, starting at day
1 for 2 weeks. In vitro
depletion of NK cells from SCID splenocytes was achieved by incubating
anti-GM1 with Low-Tox-M rabbit complement (Cedarlane). Rabbit
immunoglobulin G (IgG) was used in the control group.
Statistical analysis.
Test samples were analyzed for normal
distribution and then compared by either Student's t test
(normal distribution) or the Mann-Whitney rank sum test (nonparametric data).
 |
RESULTS |
BALB/c mice mount a greater NK cell response to Ad transgenes
compared to B6 mice.
To determine whether differences in NK
activity could explain the variable strain responses, we injected B6
and BALB/c mice with AdCAT and harvested IHL at day 0 and at days 3, 7, and 10 postinfection. Whereas the percentage and absolute number of NK cells were similar in B6 and BALB/c mice at days 0 and 3, BALB/c mice
had a significantly higher number (Fig.
1A) and proportion (Fig. 1B) of NK cells
at day 7 postinfection. Very recently, the ligands for the murine NKG2
receptor have been identified as the minor histocompatibility antigens
H-60 and Rael (3). To determine whether the NK-activating
ligand H-60 was increased in the liver following AdCAT infection, we
performed reverse transcription-PCR (RT-PCR) analysis of liver lysates.
As shown in Fig. 1C, the peak expression of NK infiltration
corresponded with an ~4-fold increase in the mRNA expression of H-60
in BALB/c but not B6 mice. To exclude the possibility that the NK
response was transgene specific, B6 and BALB/c mice were injected with
the Ad null vector and NK cells were evaluated at days 3 and 7. As
shown in Fig. 1D, the proportion of NK cells was twofold higher in
BALB/c mice but peaked at day 3 rather than day 7. The reason for the
difference in the kinetics of NK responses is uncertain but presumably
reflects modulation of NK activators by the expression of the
transgene.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
AdCAT induces increased intrahepatic NK cells in BALB/c
mice. (A and B) B6 and BALB/c mice were infected with 2 × 1010 particle of AdCAT and sacrified either before (day 0)
or at different time points after infection. IHL from three mice were
isolated and pooled, and the numbers and percentages of
DX5+ (FL2) and CD8+ (FL1) cells per liver were
determined by flow cytometry. The numbers in panel A were derived from
two separate experiments. A representative flow cytometry analysis of
IHL from day 7-infected mice is shown. (C) Total liver RNA was
collected and pooled from day 0, 3, 7, and 10 AdCAT-infected B6 and
BALB/c mice (n = 3 per group). RT-PCR was performed to
amplify the H-60 and -actin mRNA transcripts as described in
Materials and Methods. Each lane includes pooled RNA from three mice
and represents an independent experiment. N, negative control. (D) B6
and BALB/c mice were infected with 2 × 1010 particles
of Ad null and sacrificed at different time points after infection as
in panel A. IHL from each group were isolated and pooled, and the
percentages of DX5+ (FL2) and CD8+ (FL1) cells
per liver were determined by flow cytometry. Flow cytometry analysis of
IHL from day 3 infected mice is shown and is representative of three
experiments performed.
|
|
To determine whether the higher number of intrahepatic NK cells in
BALB/c mice was associated with increased NK activity, we compared
NK-mediated cytotoxicity against the target, YAC-1, at various time
points after infection. As shown in Fig.
2A, AdCAT infection induced comparable NK
cell cytotoxicity at day 3, whereas the activity at day 7 was
significantly higher in BALB/c-derived than in B6-derived IHL. A
representative example of IHL cytotoxicity at day 7 is shown in Fig.
2B. A similar increase in NK activity in BALB/c compared to B6 mice was
observed in splenic lymphocytes, whereas little to no cytotoxic
activity against this target was observed in BALB/c mice treated with
anti-GM1 (Fig. 2C). Since Liu et al. (11) reported that
hepatic enzymes such as ALT reflect NK-induced hepatocyte injury, we
quantified serum ALT in Ad null-infected mice. Whereas ALT was close to
baseline in both B6 and BALB/c mice at day 3, BALB/c mice had ~6-fold
higher serum ALT at day 7 compared to B6 mice (390 ± 107 versus
59 ± 3 U/ml [n = 6]). These findings indicate
that BALB/c mount a more intense NK response to Ad and AdCAT compared
to B6 mice.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 2.
AdCAT induces increased NK cytotoxicity in the liver and
spleen of BALB/c mice. B6 and BALB/c mice were infected with AdCAT as
in Fig. 1 and splenocytes or IHL were isolated and pooled at different
time points. NK cell cytotoxicity against YAC-1 targets was evaluated
by a Cr release assay. The percentage of specific lysis is presented at
an E/T ratio of 60:1 for IHL (A) or 200:1 for splenocytes (C). (B) IHL
cytotoxicity at different E/T ratios at day 7. The results are
representative of three experiments and expressed as the mean ± SD (A and C) or mean of triplicates ± SD. (B)
|
|
NK depletion or an intrinsic deficiency in NK cell function is
associated with extended transgene expression.
To directly address
the role of NK cell activation in the response to Ad vectors, BALB/c
mice were depleted of NK cells with anti-GM1 and infected with AdCAT or
AdsCD8, and expression of the appropriate transgene product was
quantified at weekly intervals. As shown in Fig. 3A to
C, CAT activity and serum sCD8 protein and mRNA levels were significantly higher in NK-depleted compared to
control mice injected with normal rabbit IgG at the times indicated. However, transgene expression was extinguished between weeks 4 to 6 postinfection, the time at which the rabbit antibody could no longer be
detected in the circulation (not shown).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
NK cell depletion or defective NK cell function prolongs
Ad vector expression in BALB/c or C3H mice. AdCAT (A) or AdsCD8 (B and
C)-infected BALB/c mice were injected with anti-asialo GM1 ( -GM1) or
control rabbit IgG (RIgG) as described in Materials and Methods. (D and
E) C3H/HeJ beige mice that have defective NK function were infected
with AdCAT and sCD8, respectively. Hepatic CAT activity (A and D) or
serum sCD8 protein levels (B and E) (expressed as mean ± SD) were
quantified at weekly intervals as described in Materials and Methods.
(C) AdsCD8mRNA expression assessed by RT-PCR using primers common to Ad
vector sequences flanking the transgene (Ad5' and Ad3'). -Actin was
used as a control. N, negative control from uninfected mice; NS, not
significant.
|
|
C3H/HeJ beige (beige) mice have a spontaneous mutation in the
Lyst gene leading to defective NK cell cytotoxicity
(24). To determine whether NK cells also participate in
the innate immune response to Ad vectors in C3H mice, we infected beige
mice with AdCAT or AdsCD8 and quantified transgene expression as in
BALB/c mice. CAT expression was 10- to 100-fold higher in beige mice than in strain-matched controls at 4 weeks postinfection (Fig. 3D), and
sCD8 levels were significantly higher than in wild-type controls up to
8 weeks postinfection (Fig. 3E). These findings indicate that NK cells
contribute to the attenuation of transgene expression in Ad
vector-infected cells in both BALB/c and C3H mice and that sCD8 was
expressed longer than AdCAT.
Synergistic effect of CD8+ and NK cell inhibition in
BALB/c and C3H mice.
The longer duration of expression of sCD8
compared to CAT (Fig. 3) could be explained by a more potent immune
response to the foreign transgene, CAT, or the combined effect of NK
depletion and CD8 neutralization. To test whether combined NK cell
depletion and sCD8 had a more potent effect than either alone, BALB/c
mice were depleted of NK cells and coinjected with AdsCD8 and AdCAT. As
shown in Fig. 4A, BALB/c mice that
received both transgenes had significantly higher CAT activity at day
28 postinjection than mice treated with either manipulation alone.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Attenuation of NK and CD8 function promotes synergistic
CAT expression in BALB/c and C3H mice. (A) BALB/c mice (n = 4 to 9) were infected with AdCAT and/or AdCD8 and depleted of NK
cells as shown. Hepatic CAT expression was quantified at day 7 or 28 postinfection. Error bars show SD. (B) C3H/HeJ beige or C3H/HeJ
wild-type (w.t.) mice (n = 3 per group) were infected
with AdCAT alone and AdsCD8 as shown. Hepatic CAT expression was
quantified at day 28 postinfection. Error bars show SD.
|
|
To exclude the possibility that the results observed were due to
unwanted effects of the antibody depletion, we tested whether a similar
effect could be observed in C3H beige mice. As shown in Fig. 4B, sCD8
conferred significant protection to AdCAT in both wild-type and beige
mice, but CAT expression was almost 1,000-fold higher in beige than in
to wild-type mice. These findings indicate that loss of CD8 and NK
function has a synergistic negative effect on the immune response to Ad
transgenes in BALB/c and C3H mice.
Effect of NK cell depletion or repletion on intrahepatic CD8 T-cell
infiltration.
The temporal association between NK and CD8 T-cell
infiltration in the liver of BALB/c mice in response to Ad null and
AdCAT (Fig. 1), as well as the synergistic effect of NK and CD8 T-cell function on transgene expression, suggested the possibility of a
cooperative interaction between NK and CD8+ T cells. To
examine whether NK cells could directly affect CD8 T-cell activation,
we first removed NK cells from AdCAT-infected BALB/c mice and analyzed
IHL phenotype and function at day 7 postinfection. As shown in Fig. 5A
to D, intrahepatic CD8 T cells were
reduced 4- to 5-fold, whereas no reduction of the number of CD4 T cells was observed. IHL CD8 T-cell cytotoxicity against virus-infected fibroblast targets was significantly lower in NK-depleted mice (Fig.
5E). NK cell depletion did not affect the proliferation and
cytotoxicity of splenic T cells (data not shown), indicating that the NK-CD8 T-cell interaction was compartment specific.


View larger version (80K):
[in this window]
[in a new window]
|
FIG. 5.
Depletion of NK cells selectively reduces CD8 T-cell
infiltration and function in the liver of BALB/c mice. (A to D)
AdCAT-infected BALB/c mice (n = 3 per group) were
treated with control rabbit IgG (A and C) or anti-GM1 (B and D). At day
7 postinfection, IHL were isolated, pooled, and stained for CD8, DX5,
and CD4. Two-color flow cytometry analysis from one of two experiments
with similar results is shown. The percentage of each cell type (where
>1%) is indicated in the corresponding quadrant, whereas the absolute
numbers of CD4+ and CD8+ T cells are shown
below the quadrant. In the second experiment, the cell numbers were as
follows: for CD8+, rabbit IgG, 24 × 104,
and anti-GM1, 4 × 104; for CD4+, rabbit
IgG, 10 × 104, and anti-GM1, 15 × 104. (E) IHL isolated from BABL/c mice treated as above
were directly analyzed for the ability to lyse AdCAT-infected
SVBALB(H2d) target cells. The result is
representative of two separate experiments. In the second experiment at
E/T = 50:1, percentages of cell lysis were as follows: rabbit IgG,
50 ± 7; anti-GM1, 25 ± 47; and uninfected, 27 ± 5. "Uninfected" refers to lysis observed in cells obtained from
uninfected mice.
|
|
Since antibody depletion with anti-GM1 may not be completely specific
for NK cells (27, 31), we assessed whether local CD8
T-cell function could be enhanced by increasing NK cell numbers. Since
~70% spleen cells in SCID mice are NK cells (DX5+ [data
not shown]), we transferred either total or NK-depleted SCID
splenocytes to day 1 AdCAT-infected BALB/c mice. The increased percentages of NK cell could readily be detected in the peripheral blood of the NK-depleted recipients compared to the control group at
day 1 (7.65 ± 0.47 versus 5.9 ± 0.26 [n = 6],
P = 0.01). At day 3 posttransfer, we analyzed the composition
and function of IHLs. As shown in Fig. 6A to
D, the number of intrahepatic CD8 but not
CD4 cells was higher in mice that received total SCID splenocytes than
in mice that received NK-depleted SCID splenocytes. Furthermore, CD8
CTL activity was substantially enhanced after NK cell transfer (Fig.
6E). Similar results were observed at day 7 postinfection
(CD8+ T-cell number, 21 versus 6.4 × 104;
CTL activity, 45 ± 2% versus 20 ± 0.5% at E/T ratio of
60:1 in mice receiving total [n = 3] versus
NK-depleted ([n = 3] splenocytes). These results
strongly support the idea that NK cells can directly affect the
recruitment and function of antigen-specific CD8 T cells.


View larger version (73K):
[in this window]
[in a new window]
|
FIG. 6.
Adoptive transfer of NK cells selectively enhances CD8
T-cell infiltration and function in the liver of BALB/c mice. BALB/c
mice were infected with AdCAT and at day 1 postinfection injected with
5 × 106 SCID spleen cells (Total) or an equal number
of NK-depleted SCID spleen cells. At day 3 postinfection, IHL were
isolated, pooled, and evaluated for phenotype (A to D) and CD8
cytotoxicity (E) as in Fig. 5. Similar results were obtained at day 7 postinfection (see Results). "Uninfected" refers to lysis observed
in cells obtained from uninfected cells.
|
|
The IL-12 p35 subunit is differentially expressed in BALB/c and B6
mice after infection.
The cytokines IL-12 and IL-18 are potent NK
cell activators in vivo and in vitro (32). To investigate
whether differential cytokine expression was responsible for the
greater NK activation observed in BALB/c than in B6 mice, we quantified
cytokine mRNA expression in the spleen and liver of infected mice by an
RNase protection assay. Spleen cells from B6 and BALB/c mice produced comparable levels of IL-12 p35 before viral infection (not shown), but
at days 3 and 7 postinfection, the mRNA level of p35 was two- to
threefold higher in BALB/c than in B6 mice (Fig.
7A). In the liver, neither p35 nor p40
was detected in total liver RNA derived from B6 or BALB/c mice at day 3 postinfection (not shown). However, at day 7, the p40 subunit was
detected in both strains whereas the p35 subunit was only weakly
detected in BALB/c mice (Fig. 7B).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 7.
BALB/c mice demonstrate high splenic and hepatic IL-12
p35 mRNA expression following Ad infection. B6 and BALB/c mice were
injected with 2 × 1010 particles of AdCAT or AdsCD8.
RNA from the whole spleen (A) and liver (B) was harvested at days 3 and
7 postinfection. mRNA expression was quantified by an RNase protection
assay according to the manufacturer's instructions, using 30 µg (A)
or 100 µg (B) of total RNA. A housekeeping gene (L32; short exposure
time) is shown as a control. Total liver RNA was collected from day
7(C) and day 10 (D) Ad-infected B6 and BALB/c mice. RT-PCR was
performed to amplify the p35 and p40 IL-12 mRNA transcripts as well as
-actin as described in Materials and Methods. P, positive control;
M, marker.
|
|
To confirm these findings, RT-PCR was used to amplify the p35 and p40
IL-12 transcripts from liver RNA obtained at days 7 and 10 postinfection. Consistent with the results obtained in the RNase
protection assay, hepatic p35 transcripts were higher in BALB/c than in
B6 mice at day 7 postinfection, whereas the levels of p40 transcripts
were comparable (Fig. 7C). This difference persisted until day 10 postinfection, although fewer p40 transcripts were present in the liver
of B6 compared to BALB/c mice at this time point. The different
induction pattern of the p35 subunit in both the spleen and liver of B6
compared to BALB/c mice indicates an intrinsic difference between these
two strains in their responses to Ad vector infection.
Modulation of bioactive IL-12 levels influences Ad vector
expression in BALB/c mice.
If IL-12 plays a nonredundant role in
promoting the NK response to Ad vectors in BALB/c mice, then mice with
a selective deficiency of the p35 subunit of IL-12 should demonstrate
extended expression of Ad transgenes. As shown in Fig.
8A, four of eight p35-deficient BALB/c
mice infected with AdsCD8 expressed sCD8 for at least 4 weeks
postinfection, whereas all 18 wild-type BALB/c mice eliminated AdsCD8
within ~2 weeks (20).


View larger version (32K):
[in this window]
[in a new window]
|
FIG. 8.
Modulation of IL-12 activity influences the duration of
expression of Ad vectors in BALB/c and B6 mice. (A) IL-12p35-deficient
(n = 8) and wild type (w.t) (n = 18)
BALB/c mice were infected with 2 × 1010 particles of
AdsCD8, and the serum level of sCD8 was quantified by ELISA at weekly
intervals. Error bars show SD. (B) B6 mice infected with AdsCD8 as in
panel A, received 10 ng of recombinant IL-12 or phosphate-buffered
saline (control) by intravenous injection. Serum levels of soluble CD8
were quantified as in panel A and expressed as mean ± SD.
|
|
Since B6 mice had a lower IL-12 response to Ad vectors associated with
a slower attenuation of expression of Ad vectors such as AdsCD8
(20), a second prediction from these studies is that addition of IL-12 should enhance the immune response to AdCD8 in B6
mice. As shown in Fig. 8B, the expression level of sCD8 (and CAT [data
not shown]) were significantly lower in B6 mice that had received
IL-12 than in untreated B6 mice.
Increased IL-12 expression is associated with enhanced IFN-
production by BALB/c mice.
The p40-p35 heterodimer forms bioactive
IL-12, which stimulates NK cells to produce IFN-
, whereas the
p40-p40 homodimer inhibits IL-12 function. Because p35 and p40 subunits
are differentially regulated in the liver of infected BALB/c and B6
mice and IL-12 promotes IFN-
expression (32), we
compared IFN-
production by IHL between these two strains. As shown
in Fig. 9A, the much higher increase in
IFN-
mRNA expression at day 7 in BALB/c than in B6 mice is
consistent with a role for IL-12 in augmenting IFN-
production in
BALB/c mice. Restimulation of NK cells with the YAC-1 target induced a
substantially higher level of IFN-
from day 7-infected BALB/c IHL
compared to B6 IHL. Even when exogenous IL-12 was added to the
cultures, BALB/c mice produced ~3-fold more IFN-
than did B6 mice,
in keeping with the higher number of NK cells in BALB/c livers. Taken
together, these findings indicate that bioactive IL-12 promotes immune
responses to Ad vectors by enhancing NK function, at least in part,
through increased production of IFN-
.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 9.
Increased intrahepatic production of IFN- by BALB/c
mice. (A) BALB/c and B6 mice were infected with AdCAT, and the total
liver cDNA used for Fig. 1C was used to amplify IFN- and the
-actin control by PCR. Each lane contains pooled RNA from three mice
and represents an independent experiment. (B) B6 and BALB/c mice were
infected with AdCAT as in Fig. 1. IHL were harvested on day 7, pooled,
and incubated with YAC-1 cells at a ratio of 1:10, with or without
IL-12 (10 ng/ml) in the culture medium. Culture supernatants were
collected 24 h later and assayed for IFN- concentrations by
ELISA. When IHL were incubated without YAC-1 cells, <30 U of IFN-
was detected. The results are representative of three experiments.
|
|
 |
DISCUSSION |
In this and previous (20, 21) reports, BALB/c but not
B6 mice rapidly eliminated Ad vectors expressing CAT, sCD8, Fas, and
tumor necrosis factor (TNF) receptor. Another recent study that
methodically evaluated strain variation of the expression of the
transgene hAAT also observed more rapid clearance of the Ad virus
genome in BALB/c than in B6 mice (26), although strain differences to Ad-encoded transgenes have not uniformly been found (17, 28). The rapid elimination of Ad transgene expression in BALB/c mice could not simply be explained by increased CD8 T-cell
cytotoxicity since neutralization of CD8 T-cell function or
antibody-mediated CD8 depletion only had a modest effect on transgene
expression (20). These strain differences suggested that
another early component of the host immune response was required for
rapid elimination or silencing of many Ad vectors in BALB/c mice.
NK cells play a pivotal role in the early host defense against many
viruses (reviewed in reference 2). In some cases, strain variation in resistance to the virus correlates with NK activity. For
example, in 10 of 11 mouse strains infected with murine
cytomegalovirus, resistance correlated with the extent of NK activation
(1). In the present report, we observed increased splenic
and hepatic NK cell infiltration as well as increased NK cytotoxicity
by IHL in BALB/c compared to B6 mice following AdCAT infection.
Antibody-mediated depletion of NK cells in BALB/c mice, or a
spontaneous mutation leading to defective NK function in C3H beige
mice, increased expression of AdCAT compared to their wild-type
controls. Taken together, these findings strongly support an important
role for NK cells in the immune response against AdCAT and demonstrate a heightened role for these cells in BALB/c and C3H compared to B6
mice. Of considerable interest, a fourfold increase in mRNA expression
of the minor histocompatibility antigen H-60, recently shown to be a
ligand for the NKG2 activation receptor (3), was observed
to increase around day 7 postinfection. Since H-60 is expressed in a
strain-specific fashion (BALB.B but not B6 [13]), it is
tempting to speculate that H-60 may be involved not only in NK cell
activation but also in macrophage production of TNF-
(5, 10,
21) and nitric oxide.
While these studies were in progress, Liu et al. (11)
reported that NK cells induced apoptotic liver injury associated with the release of liver enzymes (ALT) at days 6 to 9 postinfection in
Ad
-gal-infected B6 mice. Since ALT release was also observed in SCID
mice and could be attenuated by anti-GM1, apoptotic liver injury was
attributed to NK+ CD3
cells. Although
comparisons were not made between different normal strains, the authors
noted that in T-cell-deficient mice on a B6 background, poly(I-C) was
required for efficient activation of NK cells, whereas in Ad-infected
BALB/c SCID mice, NK cells were fully activated (11). We
observed that BALB/c mice had sixfold-higher serum ALT at day 7 postinfection compared to the B6 strain in response to the Ad null
vector. These results are consistent with the ~8-fold increase
observed in the study by Christ et al. (4) and the very
high ALT response in BALB/c mice infected with AdhAAT
(26). The study by Liu et al. (11) supports
an important role for NK cells in the murine innate response to
replication-defective Ad vectors, and evaluation of hepatic enzymes is
consistent with our observations that BALB/c mice have an increased NK
response to infection with Ad.
Despite the evidence for heightened NK involvement in the immune
response to Ad vectors in BALB/c and C3H mice, Ad-encoded transgenes
persist for months in BALB/c SCID mice (5), indicating that NK cells acting alone cannot eliminate Ad vectors. This
observation is not surprising since the primary role of NK cells in
response to viruses and, probably most pathogens, is to prime other
cells and pathways for effector function (2). In this
regard, we noted that increased NK infiltration in the liver of BALB/c
mice was followed by increased numbers of intrahepatic CD8+
T cells, similar to the sequence of events during murine
cytomegalovirus (16) and Rous sarcoma virus
(8) infections. Specific manipulations to either deplete
(by anti-GM) or enrich (by adoptive transfer of) NK cells resulted in
the selective reduction or increase in both numbers and activity of
intrahepatic CD8+ T cells. Together, these findings
indicate that the results are not an artifact of coexpression of
asialo-GM1 on CD4+ or CD8+ T cells
(27), but rather that the expansion and functional activity of CD8+ T cells is dependent in part on NK cells
in BALB/c mice.
Despite the sequence of events described above, attenuation of CD8
function in BALB/c mice had a modest effect on transgene expression
(20), whereas the combined blockade of NK and CD8 T-cell
function had a striking effect on transgene expression, increasing CAT
activity by several orders of magnitude in both BALB/c and C3H mice.
Although these findings could be explained by incomplete neutralization
or depletion of CD8 cells, we believe that the cumulative results are
most consistent with the idea that NK cells promote CD8 T-cell
recruitment and priming, but that the CD8 T cells produce chemokines,
cytokines, or ligands that feed back on NK cells in a positive
amplification loop. This hypothesis does not exclude additional roles
for NK1.1 (37) or other cells of the innate or adaptive
immune systems.
IL-12, a cytokine produced by macrophages or dendritic cells in
response to microbial infection (32), was originally
identified as a strong NK cell stimulator that promotes Th1
development, in part through activation of IFN-
(9).
Although IL-12 can augment CD8 CTL activity directly, this is seen with
pharmacologic rather than physiologic concentrations of IL-12
(12) Biologically active IL-12 is composed of two
subunits, p35 and p40, that are encoded by separate genes and
differentially regulated. Both subunits have to be synthesized in the
same cell to form bioactive IL-12, whereas secretion of p40 alone
results in a potent competitive inhibitor of IL-12. BALB/c mice
produced a higher level of expression of both p35 and p40 mRNA in the
liver from days 7 to 10 postinfection compared to B6 mice. Given that
most Ad particles are cleared by Kupffer cells during the first 24 h of infection (35), the delayed expression of IL-12
suggests that the source of this cytokine was infiltrating cells such
as monocytes (36, 38) rather than Kupffer cells. The
kinetics of IFN-
mRNA expression in the liver paralleled that of
IL-12 and IHL obtained from BALB/c mice showed a striking increase in
IFN-
following exposure to a NK target in vitro. Together, these
findings strongly suggest that IL-12 is instrumental in augmenting
IFN-
production and that these cytokines play a pivotal role in
the rapid extinction of Ad transgene expression in BALB/c mice.
The role of IL-12 in strain-specific regulation of the innate immune
response to Ad vectors was confirmed by manipulation of IL-12 activity
in BALB/c and B6 mice. Thus, four of eight p35-deficient BALB/c mice
demonstrated prolonged expression of sCD8, whereas administration of
low dose recombinant IL-12 reduced expression of AdsCD8 and AdCAT in B6
mice. It is not clear whether the variability in the response
p35
/
BALB/c mice is explained by a compensatory effect
of other cytokines such as IL-18 (30) which, in individual
mice, may be stochastic (23). However, the extended
expression of transgenes in p35
/
mice is highly
significant since expression of Ad-encoded transgenes beyond 2 weeks
was not observed in the wild-type controls.
The rapid extinction of Ad transgene expression in BALB/c mice
associated with enhanced IL-12 and IFN-
production and NK and CD8
T-cell activation reported here contrasts with the delayed clearance
and Th2 cytokine profile characteristic of the BALB/c immune response
to Leishmania major (19). However, the time course and cells implicated in the key effector phase are different in
these two infections. Indeed, BALB/c mice also produce significantly more IL-12 compared to B6 mice in response to L. major
infection, but this response is quenched by increased production of
macrophage-deactivating cytokines such as IL-10 and transforming growth
factor
(25) and/or by a more rapid and sustained
down-regulation of the IL-12 receptor
2 chain (29).
Unlike the response to Ad, efficient clearance of the parasite is
critically dependent on cytokine polarized CD4 T cells, whereas CD8 T
cells play a minor role (7). Since cytokines such as
IFN-
and TNF-
may attenuate transgene expression at the level of
transcription (6, 22) as well as by promoting cytotoxic
effector function, we cannot be certain whether reduced expression of
transgenes reported here was also associated with virus genome
clearance. However, in at least one other study where both transgene
and virus genome were quantified in BALB/c mice, loss of transgene
expression was associated with elimination of the Ad genome
(26).
In summary, the findings in this study provide a mechanistic
explanation for the different strain responses to Ad vectors in BALB/c
and B6 mice. Although the exaggerated responses of BALB/c mice to Ad
null reported here and elsewhere (4) strongly suggest that
there is an intrinsic strain difference in response to Ad, the nature
and level of expression of the transgene can almost certainly modulate
the quality of the immune response (17, 18, 26). In Rous
sarcoma virus infections, preexposure of mice to different
virus-encoded proteins can also profoundly alter the nature of the
immune response (8). Further attention to the role of
innate immune responses (5, 10) to both the Ad and transgene product may be required to optimize Ad-based gene delivery systems in the future.
 |
ACKNOWLEDGMENTS |
We thank Xiaojing Ma, Weill Medical College, for helpful discussions.
This work was supported in part by grant HL-9308-L (K.B.E. and E.F.-P.)
from the National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Research
Division, Hospital for Special Surgery-Weill Medical College of Cornell
University, 535 E. 70th St., New York, NY 10021. Phone: (212) 606-1409. Fax: (212) 774-2337. E-mail: elkonk{at}hss.edu.
 |
REFERENCES |
| 1.
|
Bancroft, G. J.,
G. R. Shellam, and J. E. Chalmer.
1981.
Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.
J. Immunol.
126:988-994[Abstract].
|
| 2.
|
Biron, C. A.,
K. B. Nguyen,
G. C. Pien,
L. P. Cousens, and T. P. Salazar-Mather.
1999.
Natural killer cells in antiviral defense: function and regulation by innate cytokines.
Annu. Rev. Immunol.
17:189-220[CrossRef][Medline].
|
| 3.
|
Cerwenka, A.,
A. B. Bakker,
T. McClanahan,
J. Wagner,
J. Wu,
J. H. Phillips, and L. L. Lanier.
2000.
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
Immunity
12:721-727[CrossRef][Medline].
|
| 4.
|
Christ, M.,
B. Louis,
F. Stoeckel,
A. Dieterle,
L. Grave,
D. Dreyer,
J. Kintz,
D. Ali Hadji,
M. Lusky, and M. Mehtali.
2000.
Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.
Hum. Gene Ther.
11:415-427[CrossRef][Medline].
|
| 5.
|
Elkon, K. B.,
C. C. Liu,
J. G. Gall,
J. Trevejo,
M. W. Marino,
K. A. Abrahamsen,
X. Song,
J. L. Zhou,
L. J. Old,
R. G. Crystal, and E. Falck-Pedersen.
1997.
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.
Proc. Natl. Acad. Sci. USA
94:9814-9819[Abstract/Free Full Text].
|
| 6.
|
Harms, J. S., and G. A. Splitter.
1995.
Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
Hum. Gene Ther.
6:1291-1297[Medline].
|
| 7.
|
Huber, M.,
E. Timms,
T. W. Mak,
M. Rollinghoff, and M. Lohoff.
1998.
Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.
Infect. Immun.
66:3968-3970[Abstract/Free Full Text].
|
| 8.
|
Hussell, T., and P. J. Openshaw.
1998.
Intracellular IFN-gamma expression in natural killer cells preceeds lung CD8+ T cell recruitment during respiratory syncytial virus infection.
J. Gen. Virol.
79:2593-2601[Abstract].
|
| 9.
|
Kobayashi, M.,
L. Fitz,
M. Ryan,
R. M. Hewick,
S. C. Clark,
S. Chan,
R. Loudon,
F. Sherman,
B. Perussia, and G. Trinchieri.
1989.
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
J. Exp. Med.
170:827-845[Abstract/Free Full Text].
|
| 10.
|
Lieber, A.,
C. Y. He,
L. Meuse,
D. Schowalter,
I. Kirillova,
B. Winther, and M. A. Kay.
1997.
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.
J. Virol.
71:8798-8807[Abstract].
|
| 11.
|
Liu, Z. X.,
S. Govindarajan,
S. Okamoto, and G. Dennert.
2000.
NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection.
J. Immunol.
164:6480-6486[Abstract/Free Full Text].
|
| 12.
|
Magram, J.,
S. E. Connaughton,
R. R. Warrier,
D. M. Carvajal,
C. Y. Wu,
J. Ferrante,
C. Stewart,
U. Sarmiento,
D. A. Faherty, and M. K. Gately.
1996.
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.
Immunity
4:471-481[CrossRef][Medline].
|
| 13.
|
Malarkannan, S.,
P. P. Shih,
P. A. Eden,
T. Horng,
A. R. Zuberi,
G. Christianson,
D. Roopenian, and N. Shastri.
1998.
The molecular and functional characterization of a dominant minor H antigen, H60.
J. Immunol.
161:3501-3509[Abstract/Free Full Text].
|
| 14.
|
Marshall, E.
1999.
Gene therapy death prompts review of adenovirus vector.
Science
286:2244-2245[Free Full Text].
|
| 15.
|
Matzinger, P.
1991.
The JAM test. A simple assay for DNA fragmentation and cell death.
J. Immunol. Methods
145:185-192[CrossRef][Medline].
|
| 16.
|
McIntyre, K. W., and R. M. Welsh.
1986.
Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
J. Exp. Med.
164:1667-1681[Abstract/Free Full Text].
|
| 17.
|
Michou, A. I.,
L. Santoro,
M. Christ,
V. Julliard,
A. Pavirani, and M. Mehtali.
1997.
Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
Gene Ther.
4:473-482[CrossRef][Medline].
|
| 18.
|
Morral, N.,
W. O'Neal,
H. Zhou,
C. Langston, and A. Beaudet.
1997.
Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Hum. Gene Ther.
8:1275-1286[Medline].
|
| 19.
|
Mosmann, T. R., and R. L. Coffman.
1989.
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
Annu. Rev. Immunol.
7:145-173[CrossRef][Medline].
|
| 20.
|
Peng, Y.,
E. Falck-Pedersen, and K. B. Elkon.
2000.
Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo.
J. Immunol.
165:1470-1478[Abstract/Free Full Text].
|
| 21.
|
Peng, Y.,
J. Trevejo,
J. Zhou,
M. W. Marino,
R. G. Crystal,
E. Falck-Pedersen, and K. B. Elkon.
1999.
Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.
J. Virol.
73:5098-5109[Abstract/Free Full Text].
|
| 22.
|
Qin, L.,
Y. Ding,
D. R. Pahud,
E. Chang,
M. J. Imperiale, and J. S. Bromberg.
1997.
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.
Hum. Gene Ther.
8:2019-2029[Medline].
|
| 23.
|
Reiner, S. L., and R. A. Seder.
1999.
Dealing from the evolutionary pawnshop: how lymphocytes make decisions.
Immunity
11:1-10[CrossRef][Medline].
|
| 24.
|
Roder, J., and A. Duwe.
1979.
The beige mutation in the mouse selectively impairs natural killer cell function.
Nature.
278:451-453[CrossRef][Medline].
|
| 25.
|
Scharton-Kersten, T.,
L. C. Afonso,
M. Wysocka,
G. Trinchieri, and P. Scott.
1995.
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
J. Immunol.
154:5320-5330[Abstract].
|
| 26.
|
Schowalter, D. B.,
C. L. Himeda,
B. L. Winther,
C. B. Wilson, and M. A. Kay.
1999.
Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
J. Virol.
73:4755-4766[Abstract/Free Full Text].
|
| 27.
|
Slifka, M. K.,
R. R. Pagarigan, and J. L. Whitton.
2000.
NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
J. Immunol.
164:2009-2015[Abstract/Free Full Text].
|
| 28.
|
Suzuki, M.,
R. Singh,
M. A. Moore,
W. R. Song, and R. G. Crystal.
1998.
Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes.
Hum. Gene Ther.
9:1223-1231[Medline].
|
| 29.
|
Szabo, S. J.,
A. S. Dighe,
U. Gubler, and K. M. Murphy.
1997.
Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.
J. Exp. Med.
185:817-824[Abstract/Free Full Text].
|
| 30.
|
Takeda, K.,
H. Tsutsui,
T. Yoshimoto,
O. Adachi,
N. Yoshida,
T. Kishimoto,
H. Okamura,
K. Nakanishi, and S. Akira.
1998.
Defective NK cell activity and Th1 response in IL-18-deficient mice.
Immunity
8:383-390[CrossRef][Medline].
|
| 31.
|
Trambley, J.,
A. W. Bingaman,
A. Lin,
E. T. Elwood,
S. Y. Waitze,
J. Ha,
M. M. Durham,
M. Corbascio,
S. R. Cowan,
T. C. Pearson, and C. P. Larsen.
1999.
Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.
J. Clin. Investig.
104:1715-1722[Medline].
|
| 32.
|
Trinchieri, G.
1998.
Interleukin-12: a cytokine at the interface of inflammation and immunity.
Adv. Immunol.
70:83-243[Medline].
|
| 33.
|
Watanabe, H.,
K. Ohtsuka,
M. Kimura,
Y. Ikarashi,
K. Ohmori,
A. Kusumi,
T. Ohteki,
S. Seki, and T. Abo.
1992.
Details of an isolation method for hepatic lymphocytes in mice.
J. Immunol. Methods
146:145-154[CrossRef][Medline].
|
| 34.
|
Wilson, J. M.
1996.
Adenoviruses as gene-delivery vehicles.
N. Engl. J. Med.
334:1185-1187[Free Full Text].
|
| 35.
|
Worgall, S.,
G. Wolff,
E. Falck-Pedersen, and R. G. Crystal.
1997.
Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.
Hum. Gene Ther.
8:37-44[Medline].
|
| 36.
|
Yang, Y.,
H. C. Ertl, and J. M. Wilson.
1994.
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
Immunity
1:433-442[CrossRef][Medline].
|
| 37.
|
Yang, Y., and J. M. Wilson.
1995.
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.
J. Immunol.
155:2564-2570[Abstract].
|
| 38.
|
Zhang, H. G.,
T. Zhou,
P. Yang,
C. K. Edwards III,
D. T. Curiel, and J. D. Mountz.
1998.
Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver.
Hum. Gene Ther.
9:1875-1884[Medline].
|
Journal of Virology, May 2001, p. 4540-4550, Vol. 75, No. 10
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4540-4550.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ajuebor, M. N., Jin, Y., Gremillion, G. L., Strieter, R. M., Chen, Q., Adegboyega, P. A.
(2008). {gamma}{delta}T Cells Initiate Acute Inflammation and Injury in Adenovirus-Infected Liver via Cytokine-Chemokine Cross Talk. J. Virol.
82: 9564-9576
[Abstract]
[Full Text]
-
Burt, B. M., Plitas, G., Stableford, J. A., Nguyen, H. M., Bamboat, Z. M., Pillarisetty, V. G., DeMatteo, R. P.
(2008). CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J. Leukoc. Biol.
84: 1039-1046
[Abstract]
[Full Text]
-
Iacobelli-Martinez, M., Nepomuceno, R. R., Connolly, J., Nemerow, G. R.
(2005). CD46-Utilizing Adenoviruses Inhibit C/EBP{beta}-Dependent Expression of Proinflammatory Cytokines. J. Virol.
79: 11259-11268
[Abstract]
[Full Text]
-
Yarovinsky, T. O., Mohning, M. P., Bradford, M. A., Monick, M. M., Hunninghake, G. W.
(2005). Increased Sensitivity to Staphylococcal Enterotoxin B following Adenoviral Infection. Infect. Immun.
73: 3375-3384
[Abstract]
[Full Text]
-
Maemondo, M., Saijo, Y., Narumi, K., Kikuchi, T., Usui, K., Tazawa, R., Matsumoto, K., Nakamura, T., Sasaki, K., Takahashi, M., Niitsu, Y., Nukiwa, T.
(2004). Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer. Cancer Res.
64: 4611-4620
[Abstract]
[Full Text]
-
Brown, B. D., Lillicrap, D.
(2002). Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy. Blood
100: 1133-1140
[Abstract]
[Full Text]
-
Zhang, H.-G., Xie, J., Xu, L., Yang, P., Xu, X., Sun, S., Wang, Y., Curiel, D. T., Hsu, H.-C., Mountz, J. D.
(2002). Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver. J. Virol.
76: 5692-5700
[Abstract]
[Full Text]